The dual role of the urokinase receptor system in pericellular proteolysis and cell adhesion: implications for cardiovascular function

被引:30
作者
Preissner, KT
Kanse, SM
Chavakis, T
May, AE
机构
[1] Univ Giessen, Facbereich Humanmed, Inst Biochem, D-35392 Giessen, Germany
[2] Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany
[3] Tech Univ Munich, Med Klin, D-80636 Munich, Germany
关键词
integrins; urokinase receptor; cell adhesion; proteolysis; vascular pathologies;
D O I
10.1007/s003950050157
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cell-cell and cell-matrix interactions are key events in morphogenetic processes during development and tissue remodelling. In the vascular system, overexpression of adhesion receptors such as integrins, protease (receptors) or dysregulation of adhesive interactions are directly related to the pathophysiology of cardiovascular diseases (atherosclerosis, restenosis, thrombosis) or angiogenesis-driven tumor progression. Protease cascades such as the plasminogen activation system exhibit a dual role in cell invasion by promoting pericellular proteolysis as well as by regulating cell adhesion and migration in a non-proteolytic fashion. In both these mechanisms, the urokinase receptor (uPAR) plays a central role and may become engaged in complexes with beta(1)-, beta(2)-, and beta(3)-integrins. This article will focus on the molecular and functional interactions between the uPAR system and vascular integrins and discuss implications for cardiovascular function.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 66 条
[31]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) ANTIGEN IS A PREDICTOR OF EARLY RELAPSE IN BREAST-CANCER [J].
JANICKE, F ;
SCHMITT, M ;
HAFTER, R ;
HOLLRIEDER, A ;
BABIC, R ;
ULM, K ;
GOSSNER, W ;
GRAEFF, H .
FIBRINOLYSIS, 1990, 4 (02) :69-78
[32]   The urokinase receptor is a major vitronectin-binding protein on endothelial cells [J].
Kanse, SM ;
Kost, C ;
Wilhelm, OG ;
Andreasen, PA ;
Preissner, KT .
EXPERIMENTAL CELL RESEARCH, 1996, 224 (02) :344-353
[33]   Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation [J].
Kjoller, L ;
Kanse, SM ;
Kirkegaard, T ;
Rodenburg, KW ;
Ronne, E ;
Goodman, SL ;
Preissner, KT ;
Ossowski, L ;
Andreasen, PA .
EXPERIMENTAL CELL RESEARCH, 1997, 232 (02) :420-429
[34]   alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule [J].
Kolanus, W ;
Nagel, W ;
Schiller, B ;
Zeitlmann, L ;
Godar, S ;
Stockinger, H ;
Seed, B .
CELL, 1996, 86 (02) :233-242
[35]   THE EFFECT OF ANTISENSE INHIBITION OF UROKINASE RECEPTOR IN HUMAN SQUAMOUS-CELL CARCINOMA ON MALIGNANCY [J].
KOOK, YH ;
ADAMSKI, J ;
ZELENT, A ;
OSSOWSKI, L .
EMBO JOURNAL, 1994, 13 (17) :3983-3991
[36]   Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes [J].
Lijnen, HR ;
Van Hoef, B ;
Lupu, F ;
Moons, L ;
Carmeliet, P ;
Collen, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (07) :1035-1045
[37]   PLASMINOGEN-ACTIVATOR EXPRESSION IN HUMAN ATHEROSCLEROTIC LESIONS [J].
LUPU, F ;
HEIM, DA ;
BACHMANN, F ;
HURNI, M ;
KAKKAR, VV ;
KRUITHOF, EKO .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) :1444-1455
[38]   Urokinase receptor (CD87) regulates leukocyte recruitment via β2 integrins in vivo [J].
May, AE ;
Kanse, SM ;
Lund, LR ;
Gisler, RH ;
Imhof, BA ;
Preissner, KT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (06) :1029-1037
[39]   RELEASE OF GPI-ANCHORED MEMBRANE-PROTEINS BY A CELL-ASSOCIATED GPI-SPECIFIC PHOSPHOLIPASE-D [J].
METZ, CN ;
BRUNNER, G ;
CHOIMUIRA, NH ;
NGUYEN, H ;
GABRILOVE, J ;
CARAS, IW ;
ALTSZULER, N ;
RIFKIN, DB ;
WILSON, EL ;
DAVITZ, MA .
EMBO JOURNAL, 1994, 13 (07) :1741-1751
[40]  
Min HY, 1996, CANCER RES, V56, P2428